D
Mineralys Therapeutics, Inc. MLYS
$14.25 $0.755.56%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 78.79% 62.19% 53.08% 74.22% 83.84%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 86.81% 128.77% 187.05% 136.73% 176.89%
Operating Income -86.81% -128.77% -187.05% -136.73% -176.89%
Income Before Tax -100.69% -147.55% -237.81% -149.90% -168.81%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -100.69% -147.55% -237.81% -149.90% -168.81%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -100.69% -147.55% -237.81% -149.90% -168.81%
EBIT -86.81% -128.77% -187.05% -136.73% -176.89%
EBITDA -- -- -- -- --
EPS Basic -61.02% -98.42% -172.10% -37.83% 65.07%
Normalized Basic EPS -61.02% -98.46% -172.08% -37.84% 65.06%
EPS Diluted -61.02% -98.42% -172.10% -37.83% 65.07%
Normalized Diluted EPS -61.02% -98.46% -172.08% -37.84% 65.06%
Average Basic Shares Outstanding 24.63% 24.75% 24.15% 81.31% 669.47%
Average Diluted Shares Outstanding 24.63% 24.75% 24.15% 81.31% 669.47%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings